IL317516A
(en )
2025-02-01
Rna constructs and uses thereof
EP4165049A4
(en )
2024-09-11
Isotryptamine psychoplastogens and uses thereof
IL300121A
(en )
2023-03-01
Anti-cd93 constructs and uses thereof
EP4146704A4
(en )
2024-08-28
Antibodies targeting clec12a and use thereof
EP4217389A4
(en )
2025-03-19
Anti-sclerostin constructs and uses thereof
EP4010032A4
(en )
2023-08-23
Implantable constructs and uses thereof
AU2022297443A1
(en )
2024-01-04
Novel rna therapeutics and uses thereof
AU2021400063A1
(en )
2023-06-29
Rna construct
IL319652A
(en )
2025-05-01
Rna constructs and uses thereof
IL304118A
(en )
2023-09-01
Expression constructs and uses thereof
EP4204559A4
(en )
2024-10-23
Nucleic acid-guided nucleases and use thereof
HK40112935A
(en )
2025-01-28
Rna constructs and uses thereof
HK40089626A
(en )
2023-10-20
Rna constructs and uses thereof
CA3269560A1
(en )
2024-04-11
Rna constructs and uses thereof
HK40128118A
(en )
2026-02-06
Rna constructs and uses thereof
HK40094272A
(en )
2024-01-12
Expression constructs and uses thereof
HK40109618B
(en )
2026-02-27
Il-21 polypeptides and targeted constructs
HK40108510A
(en )
2024-11-15
Il-21 polypeptides and targeted constructs
CA3297104A1
(en )
2025-01-02
Sars-cov-2 rna vaccines and uses thereof
HK40074636A
(en )
2023-01-06
Microdystrophin gene therapy constructs and uses thereof
HK40115707A
(en )
2025-04-03
Modified multabody constructs, compositions, and methods
HK40092070A
(en )
2023-12-15
Multicistronic rna vaccines and uses thereof
HK40114415A
(en )
2025-03-07
Optimized multabody constructs, compositions, and methods
HK40110512A
(en )
2024-12-20
Optimized multabody constructs, compositions, and methods
HK40117225A
(en )
2025-05-09
Modified multabody constructs, compositions, and methods targeting sars-cov-2